Trade NYXH anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Nyxoah SA (NYXH) is trading at US$1.59, up 0.96% today as of Aug 28, 13:02 EDT. The company has a market capitalisation of US$160.12M. Over the past 52 weeks, NYXH has traded between US$1.26 and US$6.87. On Syfe you can trade NYXH with $0 commission and add it to your watchlist.
| Previous close | US$1.57 |
|---|---|
| Market cap | US$160.12M |
| 52-week range | US$1.26 – US$6.87 |
| Volume | 100.88K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nyxoah SA
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
Year: 2021
Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed
Jul 7, 8:36 PM · MT Newswires
Nyxoah Receives $15 Million From European Investment Bank
Jun 17, 8:39 PM · MT Newswires
Nyxoah Raises $110 Million to Accelerate US Launch of Genio Sleep Apnea Device
Jun 10, 8:55 PM · MT Newswires
Nyxoah Closes $95 Million Stock Offering
Jun 10, 8:45 PM · MT Newswires
Nyxoah SA (NYXH) stock is trading at US$1.59, +0.96% from the previous close of US$1.57.
The market cap for Nyxoah SA (NYXH) stock is approximately US$160.12M.
The 52-week high for Nyxoah SA (NYXH) stock is US$6.87.
The 52-week low for Nyxoah SA (NYXH) stock is US$1.26.
Nyxoah SA (NYXH) does not currently pay a dividend.
Stay on top of NYXH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
